The Pan African Medical Journal (Dec 2020)

Subclinical atherosclerosis and associated risk factors among hiv-infected adults in Jos, North Central Nigeria: a cross-sectional study

  • Lucius Chidiebere Imoh,
  • Charles Chibunna Ani,
  • Kuleve Othniel Iyua,
  • Alfred Ibu Odo,
  • Ganiyu Adeniyi Amusa,
  • Godwin Osawaru Osaigbovo,
  • Christian Ogoegbulam Isichei,
  • Oche Ochai Agbaji,
  • Godwin Imade,
  • Ayuba Ibrahim Zoakah,
  • Basil Nwaneri Okeahialam,
  • Atiene Solomon Sagay

DOI
https://doi.org/10.11604/pamj.2020.37.388.21073
Journal volume & issue
Vol. 37, no. 388

Abstract

Read online

INTRODUCTION: Human immunodeficiency virus (HIV) is evolving into a leading cause of cardiovascular diseases (CVD) in sub-Saharan Africa (SSA) where the burden of HIV remains high. Atherosclerosis underlie progression to CVD. We therefore examined the prevalence of subclinical atherosclerosis and its association with traditional and non-traditional risk factors for CVD in Nigerian HIV-infected adults. METHODS: This was a cross-sectional study involving randomly selected stable HIV-infected patients with undetectable viral load attending HIV clinics at the Jos University Teaching Hospital and Faith Alive Foundation in Jos, Nigeria. Demographic data, Biophysical measurements, cardiovascular risk factors and information regarding HIV-related factors, fasting serum lipid profile, fasting plasma glucose, high-sensitivity C-reactive protein and Carotid-Intima-Media-Thickness (CIMT) were assessed. Subclinical atherosclerosis was defined using a cut-off value of mean CIMT greater than 0.78 mm. Data were analyzed with the Statistical Package for Social Sciences® (SPSS) software version 23.0 (IBM Corp., Chicago, Illinois, USA). Bivariate analysis and multivariate logistic regression were used to examine the association between risk factors of CVD and subclinical atherosclerosis. The statistical significance level was set at p = 0.05. RESULTS: A total of 148 HIV adults (70.9% being females) on Anti-Retroviral Therapy (ART) were included in this study. The prevalence of subclinical atherosclerosis was 7.4%. Among subjects with SCA, 63.6% were males and 81.8% were hypertensive. Elevated blood glucose, lipids and high-sensitivity C-reactive protein, body mass index (BMI), HIV-related parameters (duration of HIV infection, antiretroviral regimen, CD4 + cell count), current smoking status, alcohol use, were not significantly associated with subclinical atherosclerosis (p=0.05). Male gender [OR(95%CI=4.91(1.36-17.77)], age [OR(95%CI)=1.14(1.06-1.23)], Hypertension [OR(95%CI=14.4(3.03-71.86)] and Metabolic syndrome [OR(95%CI=8.34(1.73-40.18)] were significantly associated with SCA at bivariate analysis. After adjusting for age, sex and antiretroviral regimen, only increasing age [Adjusted Odds Ratio (AOR) (95% confidence Interval (CI)] = 1.12(1.01-1.25)] and hypertension [AOR (95%C1)=10.67 (1.31-87.18)], remained as independent predictors of SCA. CONCLUSION: The prevalence of subclinical atherosclerosis among HIV-infected adults is high in Nigeria. It is significantly associated with increasing age and hypertension. Traditional CVD risk factors such as dyslipidaemia, diabetes mellitus and obesity were not associated with subclinical atherosclerosis in this population.

Keywords